Biden’s HHS Pick Sought ‘March In’ Rights For Veklury; Targeted AbbVie ‘Pay For Delay’ Tactics
Executive Summary
California attorney general Xavier Becerra has sought to lower drug prices in California as part of a broader focus on health care costs, an approach he may bring to a new role in the Biden Administration.
You may also be interested in...
Six Glocal Trends That Could Lift Or Drift India Pharma In 2021
Scrip takes a look at the key trends that could play out in 2021 to shape the trajectory of Indian drug makers, including evolving dynamics in the US under a new president. Thorny India-China relations will add a layer of complexity, while firms may also want to look beyond the chief information officers as they ramp up digital engagement.
Trump Warns That US May Use Defense Production Act To Ensure COVID-19 Vaccine Supply
President’s comments follow two revelations: Pfizer’s acknowledgement that it will not meet its previously-stated vaccine production goals for 2020, and the US government’s decide to pass on additional Pfizer doses which have since been allocated to other countries.
Biden’s Pick Of Becerra To Lead HHS Puts Focus On Affordable Care Act
California attorney general Xavier Becerra, who has lead the blue-state legal defense of Obamacare, is among the nominees for Biden's health care team announced on 7 December, including Rochelle Walensky for CDC director. Missing from the list, though, is a nominee for FDA commissioner or CMS administrator.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: